Fig. 6 | Scientific Reports

Fig. 6

From: Targeting LAG3 to alter the tumor immune reactivity of CD8+T cells is a potential therapy for skin cutaneous melanoma

Fig. 6

Immune infiltration and immunotherapy analyses in SKCM. (A) Box plots of ESTIMATEScore, ImmuneScore, StromalScore, and TumorPurity between the High/Low-risk groups; (B) box plots of immune infiltration levels in the high/low-risk groups; (C) heatmap of gene expression of immune checkpoints in the High/Low-risk groups; (D) submap analysis showed immunotherapy susceptibility of the High/Low-risk groups; and (E) the top 6 differential chemotherapeutic agents between the High/Low-risk groups.

Back to article page